AREC — Arecor Therapeutics Share News
0.000.00%
- £14.35m
- £11.32m
- £5.05m
REG - Arecor Therapeutics - Grant of Options and PDMR Dealing
AnnouncementREG - Arecor Therapeutics - Final results for 2024
AnnouncementREG - Arecor Therapeutics - Notice of Results
AnnouncementREG - Arecor Therapeutics - Collaboration with global pharmaceutical partner
AnnouncementREG - Arecor Therapeutics - Arecor partnership with biopharmaceutical company
AnnouncementREG - Arecor Therapeutics - Arecor Full Year 2024 Trading Update
AnnouncementREG - Arecor Therapeutics - Orderly Cessation of Tetris Pharma Operations
AnnouncementREG - Arecor Therapeutics - Change of Nominated Advisor and Joint Broker
AnnouncementREG - Arecor Therapeutics - Arecor Signs Exclusive Licensing Agreement
AnnouncementREG - Arecor Therapeutics - Grant of Options and PDMR Dealing
AnnouncementREG - Arecor Therapeutics - Arecor Appoints Interim Chief Financial Officer
AnnouncementRCS - Arecor Therapeutics - Arecor to present on Investor Meet Company
AnnouncementREG - Arecor Therapeutics - Interim Results for six months ended 30 June 2024
AnnouncementREG - Arecor Therapeutics - Notice of Results
AnnouncementREG - Arecor Therapeutics - Arecor presents positive AT278 data at EASD
AnnouncementRCS - Arecor Therapeutics - Arecor announces AT278 presentation at EASD 2024
AnnouncementREG - Arecor Therapeutics Calculus Capital Ltd - Holding(s) in Company
AnnouncementREG - Arecor Therapeutics Oxford Tech 2 VCT - Holding(s) in Company
AnnouncementREG - Arecor Therapeutics - Holding(s) in Company
Announcement